LeMaitre Vascular Inc  

(Public, NASDAQ:LMAT)   Watch this stock  
Find more results for LMAT
-0.61 (-4.61%)
Sep 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.35 - 13.11
52 week 6.48 - 14.82
Open 13.01
Vol / Avg. 118,139.00/144,585.00
Mkt cap 234.24M
P/E 37.57
Div/yield 0.04/1.27
EPS 0.34
Shares 17.72M
Beta -0.14
Inst. own 53%
Oct 26, 2015
Q3 2015 LeMaitre Vascular Inc Earnings Release (Estimated) Add to calendar
Aug 26, 2015
LeMaitre Vascular Inc at Three Part Advisors Midwest IDEAS Investor Conference
Aug 12, 2015
LeMaitre Vascular Inc at Canaccord Genuity Growth Conference
Aug 5, 2015
LeMaitre Vascular Inc at CFA Society of Minnesota's InvestMNt Conference
Jul 28, 2015
Q2 2015 LeMaitre Vascular Inc Earnings Call - Webcast
Jul 28, 2015
Q2 2015 LeMaitre Vascular Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 8.88% 5.51%
Operating margin 14.04% 8.92%
EBITD margin - 14.67%
Return on average assets 8.71% 5.15%
Return on average equity 10.24% 6.28%
Employees 325 -
CDP Score - -


63 2ND AVE
United States - Map
+1-781-2212266 (Phone)
+1-781-4255049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic patches, biologic grafts, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, angioscopes and powered phlebectomy devices. The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Officers and directors

George W. LeMaitre Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David B. Roberts President, Director
Age: 51
Bio & Compensation  - Reuters
Joseph P. Pellegrino Jr. Chief Financial Officer
Age: 50
Bio & Compensation  - Reuters
Peter R. Gebauer President - International Operations
Age: 61
Bio & Compensation  - Reuters
Trent G. Kamke Senior Vice President - Operations
Age: 44
Bio & Compensation  - Reuters
Cornelia W. LeMaitre Vice President - Human Resources, Director
Age: 79
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Lawrence J. Jasinski Independent Director
Age: 57
Bio & Compensation  - Reuters
John J. O'Connor Independent Director
Age: 67
Bio & Compensation  - Reuters
John A. Roush Independent Director
Age: 50
Bio & Compensation  - Reuters
Michael H. Thomas Independent Director
Age: 63
Bio & Compensation  - Reuters